Fentora
Total Payments
$12,754
Transactions
9
Doctors
8
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $12,754 | 9 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12,754 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) program | Teva Pharmaceuticals USA, Inc. | $12,754 | 8 |
Top Doctors Receiving Payments for Fentora
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Anesthesiology | Naples, FL | $4,264 | 2 |
| , MD | Internal Medicine | Mansfield, NJ | $1,424 | 1 |
| , MD | Anesthesiology | River Ridge, LA | $1,386 | 1 |
| , M.D | Pediatric Nephrology | New York, NY | $1,386 | 1 |
| , MD | Internal Medicine | Penn Valley, PA | $1,376 | 1 |
| , MD | Internal Medicine | Baltimore, MD | $1,039 | 1 |
| , M.D., PH.D | Clinical Pharmacology | Kansas City, MO | $1,013 | 1 |
| , M.D | Pulmonary Disease | Park Ridge, NJ | $867.57 | 1 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $12,754
Product Information
- Type Drug
- Total Payments $12,754
- Total Doctors 8
- Transactions 9
About Fentora
Fentora is a drug associated with $12,754 in payments to 8 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2018 to 2018. In 2018, $12,754 was paid across 9 transactions to 8 doctors.
The most common payment nature for Fentora is "Unspecified" ($12,754, 100.0% of total).
Fentora is associated with 1 research study, including "Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) program" ($12,754).